Amy Herr
Vermogen: 148 838 $ op 31-05-2026
Vermogen: 148 838 $ op 31-05-2026
Amy E.
Herr is the founder of Zephyrus Biosciences, Inc. (2013).
Dr. Herr is an Independent Director at Bio-Techne Corp.
since 2025.
Formerly, Vice President at Chan Zuckerberg Biohub.
Education includes a doctorate from Stanford University and an undergraduate degree from California Institute of Technology.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 08-05-2026 | 2.880 ( 0% ) | 148 838 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| BIO-TECHNE CORPORATION | Directeur/Bestuurslid | 01-01-2025 |
| Bedrijven | Functie | Einde |
|---|---|---|
Chan Zuckerberg Biohub
Chan Zuckerberg Biohub Packaged SoftwareTechnology Services Develops technology for medical researcher | Corporate Officer/Principal | - |
Zephyrus Biosciences, Inc.
Zephyrus Biosciences, Inc. BiotechnologyHealth Technology Provides tools for protein analysis at the single cell level | Oprichter | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Bio-Techne Corp.
Bio-Techne Corp. BiotechnologyHealth Technology Manufactures and sells biological products | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zephyrus Biosciences, Inc.
Zephyrus Biosciences, Inc. BiotechnologyHealth Technology Provides tools for protein analysis at the single cell level | Health Technology |
Chan Zuckerberg Biohub
Chan Zuckerberg Biohub Packaged SoftwareTechnology Services Develops technology for medical researcher | Technology Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau